Healthcare M&A and Valuation
News and Insights

The infusion therapy market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases,...

On March 11, 2025, Better Choice Company, Inc. (NYSE American: BTTR) signed a binding Letter of Intent to acquire  100 % of Choice Specialty Pharmacy Group, a fully licensed U.S. provider of specialty pharmacy and infusion clinic services with an integrated sterile compounding facility, under an option purchase agreement. The transaction, which is expected to close later in 2025 following exercise of the option, strengthens Better Choice’s footprint in healthcare services alo